NCT00507962View on ClinicalTrials.gov

Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement

PHASE1CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Advanced Cancer
Interventions
DRUG

Cisplatin

100 mg/m\^2 Intraarterial On Day 1 Every 4 Weeks

DRUG

Liposomal Doxorubicin

Starting dose 20 mg/m\^2 IV On Day 1 Every 4 Weeks

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00507962 - Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement | Biotech Hunter | Biotech Hunter